Rick E. Winningham - 15 Mar 2024 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Rick E. Winningham
Issuer symbol
TBPH
Transactions as of
15 Mar 2024
Transactions value $
$23,363
Form type
4
Filing time
19 Mar 2024, 18:06:26 UTC
Previous filing
22 Feb 2024
Next filing
04 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Award $23,362 +2,704 +0.17% $8.64 1,561,473 15 Mar 2024 Direct F1
transaction TBPH Ordinary Shares Gift $0 -7,000 -0.45% $0 1,554,473 15 Mar 2024 Direct F2
transaction TBPH Ordinary Shares Gift $0 -3,900 -0.25% $0 1,550,573 15 Mar 2024 Direct F3
transaction TBPH Ordinary Shares Gift $0 +3,900 $0 3,900 15 Mar 2024 As Custodian F3, F4
holding TBPH Ordinary Shares 92,567 15 Mar 2024 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects an acquisition from the Issuer pursuant to a restricted share purchase agreement under the Issuer's Amended and Restated 2013 Equity Incentive Plan at a per-share price equal to the closing per-share price of the Issuer's ordinary shares on the Nasdaq Global Market on March 15, 2024. Transaction was with the Issuer and did not involve an open market transaction.
F2 Bona Fide Gift. No compensation was given to the donor for the gifting of shares.
F3 Reflects the gift of shares by the Reporting Person to a custodial account established pursuant to the Uniform Transfer to Minors Act ("UTMA"), for which the Reporting Person serves as a custodian.
F4 The shares are held for grandchildren of the Reporting Person through a UTMA account, for which the Reporting Person serves as custodian. The Reporting Person disclaims beneficial ownership of these shares, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of his grandchildren's shares for purposes of Section 16 or for any other purpose.